Safety and Efficacy Study of Asfotase Alfa in Adolescents and Adults With Hypophosphatasia (HPP)

NCT01163149 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

19

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypophosphatasia

Interventions

DRUG: asfotase alfa
DRUG: asfotase alfa

Sponsor

Alexion Pharmaceuticals, Inc.